2m 2m 2m 2m 2m 2m 2m
DESIGN THERAP (DSGN)
NASDAQ
$14.98-$0.010 (-0.07%)
Price as of Aug 21, 2026 7:31 PM EDT- $938.1MMarket Cap
- 184.98%1-Year Change
- BiotechnologyIndustry
DESIGN THERAP (DSGN)
$14.98-$0.010 (-0.07%)
DSGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.99 | ||
Change | -$0.57 (-3.66%) | ||
Open | $15.66 | ||
High | $15.83 | ||
Low | $14.97 | ||
Previous Close | $15.56 | ||
Volume | 552,135 | ||
30-Day Average Volume | 477,927 | ||
1-Week Change | 1.08% | ||
1-Month Change | 24.30% | ||
1-Year Change | 184.98% | ||
3-Year Change | 631.22% | ||
5-Year Change | 0.20% | ||
Fundamentals | |||
Shares Outstanding | 62.6M | ||
Total Assets | $215.1M | ||
Market Cap | $938.1M | ||
Enterprise Value | $925.2M | ||
Period: QTR TTM FY | |||
Revenue | $2.0M | ||
Net Income | -$20.2M | ||
Free Cash Flow | -$15.5M | ||
EBIT | -$20.2M | ||
EBITDA | -$20.0M | ||
Net Working Capital | $200.8M | ||
EPS | -$0.32 | ||
Enterprise Value/EBITDA | -46 | ||
Enterprise Value/Revenue | 460 | ||
P/B | 5 | ||
P/E | -47 | ||
PEG | 5 | ||
Price/Free Cash Flow | -60 | ||
Price/Operating Cash Flow | -60 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue